SCOTTSDALE, Ariz., May 31, 2005 (PRIMEZONE) -- Desert Health Products, Inc. (OTCBB:DHPI) announces that its Egyptian customer operating under Desert Health's Royal label and logo is expanding its market share in Egypt. We received a purchase order in the amount of $76,000 in the first quarter of 2005 for 500 kilos of Babe-Ton, a natural cough, common cold and immuno-stimulant formula for adults and children, and 1200 kilos of ProcTan S.T., a male enhancement formula. The Babe-Ton has been shipped and the ProcTan will be shipped by June 15, 2005. Additionally, this customer is planning to introduce three to five new products from our list of products within the next few months.
Mr. Ahmed Naby, Vice President of Alesraa, says, "Our market has been expanding very rapidly, and we expect it to keep this wonderful fast pace for the coming years. We expect to be placing orders for the same quantities every three to four months."
Johnny Shannon, Chairman and CEO of Desert Health, says, "We have worked diligently for several years with this customer to obtain the registration of various formulas, labels and logos, and it is gratifying to see the acceptance and recognition of our product lines and labels. The success of this project is owed to the great cooperation and support of Mr. Ahmed Naby, in registering and developing this market over the last few years and we look forward to a continued success between our companies."
DHPI is an international distributor of nutrition and dietary supplements. DHPI has implemented a global commercialization strategy for its diversified line of nutritional products. DHPI strives to give the customer the best quality vitamins and minerals at the most competitive prices.
Safe Harbor Statement: This release contains statements that are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current estimates and projections about Desert Health Products, Inc.'s business, which are derived in part on assumptions of its management, and are not guarantees of Desert Health Products, Inc.'s future performance, as such performance is difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Such factors include, but are not limited to, those described in Desert Health Products, Inc.'s Annual Report on Form 10-KSB for the year ended December 31, 2004, and its Quarterly Report on Form 10-QSB for the three-month period ended March 31, 2005, which are filed with the U.S. Securities and Exchange Commission. Readers of this release are referred to those filings. Desert Health Products, Inc. does not intend to update any of these forward-looking statements after the date of this release.